Skip to main navigation Skip to search Skip to main content

Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment of acute bronchitis: multicenter, randomized, double-blinded, active-controlled, parallel, therapeutic confirmatory clinical trial

  • Kyung Il Han
  • , Tae Hyung Kim
  • , Seung Won Ra
  • , Hyoung Kyu Yoon
  • , Deog Kyeom Kim
  • , Chin Kook Rhee
  • , Jung Woong Park
  • , Yong il Hwang
  • , Hye Yun Park
  • , Yee Hyung Kim
  • , Yong Bum Park
  • , Kyeong Cheol Shin
  • , Seong Yong Lim
  • , Kwang Ha Yoo
  • Hanyang University
  • University of Ulsan
  • The Catholic University of Korea
  • Seoul National University
  • Gachon University
  • Hallym University
  • Kyung Hee University
  • Yeungnam University
  • Kangbuk Samsung Hospital
  • Konkuk University

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Acute bronchitis is the most common respiratory disease. Mixture of Ivy Leaf Extract and Coptidis rhizome syrup has shown good treatment efficacy against chronic bronchitis and acute respiratory infections. This study aimed to evaluate the efficacy and safety of Mixture of Ivy Leaf Extract and Coptidis rhizome compared with those of Pelargonium sidoides extract, for the treatment of acute bronchitis. Methods: We performed a multicenter, randomized, double-blind, active-controlled, parallel phase III study in 220 patients with acute bronchitis. The participants were offered either Mixture of Ivy Leaf Extract and Coptidis rhizome syrup (AGS) and placebo of P. sidoides tablet or placebo syrup and active tablet of P. sidoides (AGU) for 7 days. The primary endpoint was the change in the Bronchitis Severity Score (BSS) from the baseline visit (visit 2) to day 7 (visit 3). Results: For the primary outcome, there was no significant difference in the change of total BSS between visits 2 and 3 (−4.10 ± 1.93 vs. −4.24 ± 1.85, p = 0.5125), and since the upper limit of the confidence interval (1.00) was smaller than the predetermined non-inferiority margin (1.17), it was confirmed that the AGS group was non-inferior to the AGU group. The changes in each symptom in the BSS between visits 2 and 3 also showed no significant differences. The overall improvement rate measured by the investigator (91.7 vs. 89.7%; p = 0.3506) and the satisfaction rate of the participants at visit 3 also showed no significant differences (97.2 vs. 94.4%; p = 0.4388). Regarding safety issues, adverse reactions were noted in both groups similarly, with no serious adverse events (4.55 vs. 3.64%, p > 0.999). Conclusion: Mixture of Ivy Leaf Extract and Coptidis rhizome syrup is as effective and safe as P. sidoides in controlling symptoms of acute bronchitis.

Original languageEnglish
Pages (from-to)1235-1243
Number of pages9
JournalCurrent Medical Research and Opinion
Volume40
Issue number7
DOIs
StatePublished - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Acute bronchitis
  • bronchitis severity score
  • herbal product
  • mixture of ivy leaf extract and coptidis rhizome
  • Pelargonium sidoides

Fingerprint

Dive into the research topics of 'Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment of acute bronchitis: multicenter, randomized, double-blinded, active-controlled, parallel, therapeutic confirmatory clinical trial'. Together they form a unique fingerprint.

Cite this